Inhibition of human papillomavirus type 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives

Antiviral Research

Volumn 47, Issue 1, 2000, Pages 19-28

  Craigo, Jodi ^a   Callahan, Michelle ^a   Huang, Ru Chih C ^b   Delucia, Angelo L ^a  

^a Universities College of Medicine and Pharmacy   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Human papillomavirus; Larrea tridentata; Plant lignan

Indexed keywords

3' O METHYLNORDIHYDROGUAIARETIC ACID; LIGNAN DERIVATIVE; NORDIHYDROGUAIARETIC ACID; TETRAACETYLNORDIHYDROGUAIARETIC ACID; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; GENE EXPRESSION; HUMAN; HUMAN CELL; METHYLATION; NONHUMAN; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS INHIBITION; WART VIRUS;

ANTIVIRAL AGENTS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HIV LONG TERMINAL REPEAT; HUMANS; LIGNANS; NORDIHYDROGUAIARETIC ACID; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); SIMIAN VIRUS 40; TUMOR CELLS, CULTURED;

EID: 0033877123     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00089-9     Document Type: Article

References (30)

1. Apt D., Watts R.M., Suske G., Bernard H.-U. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology. 224:1996;281-291.
2. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., Struhl, K., 1994. Current Protocols in Molecular Biology, Wiley, USA.
3. Butz K., Shahabeddin L., Geisen C., Spitkovsky D., Ullmann A., Hoppe-Seyler F. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene. 10:1995;927-936.
4. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chrmosensitivity testing. Cancer Res. 47:1987;936-942.
5. Chen H., Teng L., Li J.-N., Park R., Mold D.E., Gnabre J., Hwu J.R., Tseng W.N., Huang R.C.C. Antiviral activities of methylated nordihydroguaiaretic acids (II) targeting HEPES simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J. Med. Chem. 41(16):1998;3001-3007.
6. Daelemans D., Vandamme A.M., De Clercq E. Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy. Antivir. Chem. Chemother. 10:1999;1-14.
7. Gloss B., Bernard H.-U. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 protein by a sequence-aberrant Sp1 distal element. J. Virol. 64:1990;5577-5584.
8. Gnabre J.N., Huang R.C., Bates R.B., Burns J.J., Calder S., Malcomson M.E., McClure K.J. Characterization of anti-HIV lignans from Larrea tridentata. Tetrahedron. 51:1995a;12203.
9. Gnabre J.N., Brady J.N., Clanton D.J., Ito Y., Dittmer J., Bates R.B., Huang R.C.C. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc. Natl. Acad. Sci. USA. 92:1995b;11239-11243.
10. Gnabre J.N., Ito Y., Ma Y., Huang R.C. Isolation of anti-HIV-1 lignans from Larrea tridentata by counter-current chromatography. J. Chromatogr. A719:1996;353-364.
11. Howley P.M. Role of the human papillomaviruses in human cancer. Cancer Res. (Suppl.). 51:1991;5019s-5022s.
12. Hwu J.R., Tseng W.N., Gnabre J., Giza P., Huang R.C.C. Antiviral activities of methylated nordihydroguaiaretic acids (I) synthesis, structure identification and inhibition of Tat regulated HIV transactivation. J. Med. Chem. 41(16):1998;2994-3000.
13. Jeon S., Lambert P.F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA. 92:1995;1654-1658.
14. Kreider J.W., Howett M.K., Leure Dupree A.E., Zaino R.J., Weber J.A. Laboratory production in vivo of infectious human papillomavirus type 11. J. Virol. 61:1987;590-593.
15. Meyers C., Frattini M.G., Hudson J.B., Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science. 257:1992;971-973.
16. Nguyen V.T., Morange M., Bensaude O. Firefly luciferase luminescence assays using scintillation counters for quantitation in transfected mammalian cells. Anal. Biochem. 171:1988;404-408.
17. O'Conner M., Chan S.Y., Bernard H.U. Transcription factor binding sites in the long control region of genital HPVs. Myers G., Bernard H.U., Delius H., Baker C., Icenogle J., Halpern A., Wheeler C. Human Papillomaviruses 1995 Compendium. 1995;Los Alamos National Laboratory, Los Alamos, NM.
18. Parker J.N., Zhao W., Askins K.J., Broker T.R., Chow L.T. Mutational analysis of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes. Cell Growth Differ. 8:1997;751-762.
19. Parks C.L., Shenk T. Activation of the adenovirus major late promoter by transcription factors MAZ and Sp1. J. Virol. 71:1997;9600-9607.
20. Scheffner M., Mgnger K., Byrne J.C., Howley P.M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA. 88:1991;5523-5527.
21. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 314:1985;111-114.
22. Smotkin D., Wettstein F.O. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc.Natl. Sci. USA. 83:1986;4680-4684.
23. Stanley M.A. Replication of human papillomaviruses in cell culture. Antivir. Res. 24:1994;1-15.
24. Strober, W., 1997. Trypan blue exclusion test of cell viability. In: Coligan, J.E., Kruisbeck, A.M., Margulies, D.H., Shevach, E.M., Strober, W. (Eds.), Current Protocols in Immunology, Wiley, New York, pp. Appendix 3B.
25. Tjian R.A.M.T. Transcriptional activation: a complex puzzle with few easy pieces. Cell. 77:1994;5-8.
26. von Knebel Doeberitz M., Rittmuller C., zur Hausen H., Durst M. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 antisense RNA. Int. J. Cancer. 51:1992;831-834.
27. Yee C.L., Krishnan-Hewlett I., Baker C.C., Schlegal R., Howley P.M. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119:1985;3261-3266.
28. Zhao W., Chow L.T., Broker T.R. Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes. J. Virol. 71(11):1997;8832-8840.
29. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 184:1991;9-13.
30. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta. 1288:1996;F55-F78.